athenahealth (ATHN) Given a $138.00 Price Target at Leerink Swann

athenahealth (NASDAQ:ATHN) has been given a $138.00 price objective by investment analysts at Leerink Swann in a report issued on Thursday. The brokerage currently has a “hold” rating on the health services provider’s stock. Leerink Swann’s price target would suggest a potential upside of 8.20% from the stock’s current price.

ATHN has been the topic of a number of other research reports. BidaskClub raised athenahealth from a “strong sell” rating to a “sell” rating in a research note on Saturday, October 13th. Cowen reaffirmed a “hold” rating and set a $150.00 price objective on shares of athenahealth in a research note on Wednesday, August 1st. Royal Bank of Canada reaffirmed a “hold” rating and set a $140.00 price objective on shares of athenahealth in a research note on Friday, September 28th. SunTrust Banks decreased their price objective on athenahealth to $150.00 in a research note on Wednesday, September 19th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $145.00 price objective on shares of athenahealth in a research note on Tuesday, September 18th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $153.79.

athenahealth stock opened at $127.54 on Thursday. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $5.01 billion, a price-to-earnings ratio of 81.24, a PEG ratio of 2.18 and a beta of 0.97. athenahealth has a fifty-two week low of $116.77 and a fifty-two week high of $163.94.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Monday, July 30th. The health services provider reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.47. The business had revenue of $323.30 million for the quarter, compared to analyst estimates of $334.77 million. athenahealth had a return on equity of 14.71% and a net margin of 8.71%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.51 earnings per share. Equities analysts predict that athenahealth will post 3.22 EPS for the current year.

In related news, insider Daniel P. Haley sold 2,204 shares of the stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $127.23, for a total transaction of $280,414.92. Following the transaction, the insider now directly owns 10,555 shares in the company, valued at $1,342,912.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 2,654 shares of company stock worth $340,770 over the last quarter. 2.90% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Round Table Services LLC raised its holdings in shares of athenahealth by 42.6% during the 3rd quarter. Round Table Services LLC now owns 4,518 shares of the health services provider’s stock valued at $604,000 after buying an additional 1,350 shares during the period. Oppenheimer Asset Management Inc. grew its stake in athenahealth by 8.8% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 38,028 shares of the health services provider’s stock valued at $5,081,000 after purchasing an additional 3,073 shares in the last quarter. Russell Investments Group Ltd. grew its stake in athenahealth by 76.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 22,762 shares of the health services provider’s stock valued at $3,041,000 after purchasing an additional 9,860 shares in the last quarter. Alps Advisors Inc. grew its stake in athenahealth by 14.3% during the 3rd quarter. Alps Advisors Inc. now owns 4,179 shares of the health services provider’s stock valued at $558,000 after purchasing an additional 523 shares in the last quarter. Finally, First Trust Advisors LP grew its stake in athenahealth by 3.8% during the 3rd quarter. First Trust Advisors LP now owns 118,271 shares of the health services provider’s stock valued at $15,801,000 after purchasing an additional 4,356 shares in the last quarter.

About athenahealth

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Recommended Story: Outstanding Shares and The Effect on Share Price

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply